994 related articles for article (PubMed ID: 17284958)
21. Langerhans cell histiocytosis mimicking malignant melanoma: a diagnostic pitfall.
Billings TL; Barr R; Dyson S
Am J Dermatopathol; 2008 Oct; 30(5):497-9. PubMed ID: 18806499
[TBL] [Abstract][Full Text] [Related]
22. Granular cell atypical fibroxanthoma.
Rudisaile SN; Hurt MA; Santa Cruz DJ
J Cutan Pathol; 2005 Apr; 32(4):314-7. PubMed ID: 15769283
[TBL] [Abstract][Full Text] [Related]
23. KBA.62: a useful marker for primary and metastatic melanomas.
Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
[TBL] [Abstract][Full Text] [Related]
24. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
[TBL] [Abstract][Full Text] [Related]
25. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?
Karimipour DJ; Lowe L; Su L; Hamilton T; Sondak V; Johnson TM; Fullen D
J Am Acad Dermatol; 2004 May; 50(5):759-64. PubMed ID: 15097961
[TBL] [Abstract][Full Text] [Related]
26. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
27. Compound melanocytic nevi with granular cell changes.
El-Gamal HM; Robinson-Bostom L; Saddler KD; Pan T; Mihm MC
J Am Acad Dermatol; 2004 May; 50(5):765-6. PubMed ID: 15097962
[TBL] [Abstract][Full Text] [Related]
28. Microphthalmia transcription factor: a specific marker for malignant melanoma.
Vachtenheim J; Borovanský J
Prague Med Rep; 2004; 105(3):318-24. PubMed ID: 15782558
[TBL] [Abstract][Full Text] [Related]
29. Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Mod Pathol; 2001 Jan; 14(1):6-9. PubMed ID: 11211309
[TBL] [Abstract][Full Text] [Related]
30. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
[TBL] [Abstract][Full Text] [Related]
31. Skin layer-specific Melan-A expression during progression of human cutaneous melanoma: implications for diagnostic applications of the marker.
Sztramska A; Dymerska D; Chwirot BW
Melanoma Res; 2008 Aug; 18(4):259-67. PubMed ID: 18626310
[TBL] [Abstract][Full Text] [Related]
32. Idiosyncrasies of scalp melanoma.
Rigual NR; Cheney RT; Iwenofu OH; Li Q; Loree TR; Popat SR; Merzianu M
Laryngoscope; 2007 Aug; 117(8):1354-8. PubMed ID: 17592396
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
Nonaka D; Chiriboga L; Rubin BP
J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
[TBL] [Abstract][Full Text] [Related]
34. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma.
Dotto JE; Glusac EJ
J Cutan Pathol; 2006 Jun; 33(6):413-7. PubMed ID: 16776716
[TBL] [Abstract][Full Text] [Related]
35. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms.
McCluggage WG; Bissonnette JP; Young RH
Int J Gynecol Pathol; 2006 Oct; 25(4):321-9. PubMed ID: 16990706
[TBL] [Abstract][Full Text] [Related]
36. Expression of calretinin and the alpha-subunit of inhibin in granular cell tumors.
Fine SW; Li M
Am J Clin Pathol; 2003 Feb; 119(2):259-64. PubMed ID: 12579997
[TBL] [Abstract][Full Text] [Related]
37. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
38. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
Steuhl KP; Rohrbach JM; Knorr M
Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
[TBL] [Abstract][Full Text] [Related]
39. P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.
Sigal AC; Keenan M; Lazova R
Am J Dermatopathol; 2012 Apr; 34(2):145-50. PubMed ID: 22207443
[TBL] [Abstract][Full Text] [Related]
40. Identification of nodal metastases in melanoma using sox-10.
Jennings C; Kim J
Am J Dermatopathol; 2011 Jul; 33(5):474-82. PubMed ID: 21552103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
